Basel Medical Group Ltd (BMGL) stock

BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 3/30

$0.47−0.10 (-17.54%)

Close on Nov 13, 2026Market cap $743.59KP/E –Yield –

Basel Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Basel Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Basel Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Jun 22, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BMGL.

Revenue growth45.2% · median -15.3%

Net margin-4.5% · median -63.1%

Advertisement
300 × 250

See a number that looks wrong?